New medicines save lives, but they take too long to get to market. Could AI make a difference?

A selection of experts from Asahi Kasei Bioprocess discuss the key practices behind successful processes.

Cell and Gene therapies have come a long way since the 1970s. Technology, combined with knowledge, will take them even further.

Jon Thomas, CEO of CIRM, discusses the evolution of stem cell research and the future of regenerative medicine in this interview.

What happens when freezers fail? Experts look at the lessons that can be learned from catastrophic power outages.

Understanding how choices in chromatography solutions impact overall process efficiency.

Personalized medicine, digital therapeutics, and GLP-1s; experts tell us what areas are hot in pharma’s future.

We find out why Cas12l incorporated into a gene-writing system could help advance the field of gene editing.

Unethical practices and forced labor exist in HPMC supply chains. Here’s what can be done about it.

Pharma companies are well accustomed to supply chain issues, but how prepared are they for issues impacting access to medical devices?